{
    "nct_id": "NCT02006641",
    "title": "Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil",
    "status": "COMPLETED",
    "last_update_time": "2018-01-23",
    "description_brief": "To establish efficacy of Idalopirdine as adjunctive therapy to donepezil for symptomatic treatment of patients with mild-to-moderate Alzheimer's disease (AD).",
    "description_detailed": "The study consisted of a screening period (up to 2-week period from screening to randomization), a 24-week double-blind treatment period with placebo or idalopirdine 10 mg/day or 30 mg/day as adjunctive therapy to donepezil 10 mg/day, and a 4-week safety follow-up period following study completion or withdrawal from treatment.",
    "phase": [
        "PHASE3"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": {
        "participantFlowModule": {
            "groups": [
                {
                    "id": "FG000",
                    "title": "Placebo",
                    "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally"
                },
                {
                    "id": "FG001",
                    "title": "Idalopirdine 10 mg",
                    "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                },
                {
                    "id": "FG002",
                    "title": "Idalopirdine 30 mg",
                    "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "284"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "290"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "284"
                                }
                            ]
                        },
                        {
                            "type": "Treated",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "282"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "285"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "281"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "258"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "257"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "248"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "26"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "33"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "36"
                                }
                            ]
                        }
                    ],
                    "dropWithdraws": [
                        {
                            "type": "Withdrawal before treatment",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "2"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "5"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "3"
                                }
                            ]
                        },
                        {
                            "type": "Adverse Event",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "15"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "11"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "15"
                                }
                            ]
                        },
                        {
                            "type": "Protocol Violation",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "2"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "2"
                                }
                            ]
                        },
                        {
                            "type": "Lost to Follow-up",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Withdrawal by Subject",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "7"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "12"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "11"
                                }
                            ]
                        },
                        {
                            "type": "Other reason: patient didn't show up",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Other reason:patient didn't want to come",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "1"
                                }
                            ]
                        },
                        {
                            "type": "Other reason: patient has moved",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "1"
                                }
                            ]
                        },
                        {
                            "type": "Other reason: caregiver in hospital",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Other reason: patient's wife has died",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "1"
                                }
                            ]
                        },
                        {
                            "type": "Other reason: hospitalisation",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Other reason: caregiver impossibility",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "1"
                                }
                            ]
                        },
                        {
                            "type": "Other reason: protocol non-compliance",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "1"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "populationDescription": "A total of 858 patients were randomized into the study but 10 patients were not treated (did not receive IMP). The baseline analysis population only consist of patients who have been treated.",
            "groups": [
                {
                    "id": "BG000",
                    "title": "Placebo",
                    "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally"
                },
                {
                    "id": "BG001",
                    "title": "Idalopirdine 10 mg",
                    "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                },
                {
                    "id": "BG002",
                    "title": "Idalopirdine 30 mg",
                    "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                },
                {
                    "id": "BG003",
                    "title": "Total",
                    "description": "Total of all reporting groups"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "282"
                        },
                        {
                            "groupId": "BG001",
                            "value": "285"
                        },
                        {
                            "groupId": "BG002",
                            "value": "281"
                        },
                        {
                            "groupId": "BG003",
                            "value": "848"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Continuous",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "years",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "73.4",
                                            "spread": "8.3"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "74.9",
                                            "spread": "8.1"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "75.0",
                                            "spread": "8.0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "74.4",
                                            "spread": "8.1"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "181"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "172"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "169"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "522"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "101"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "113"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "112"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "326"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Ethnicity (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "10"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "11"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "10"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "31"
                                        }
                                    ]
                                },
                                {
                                    "title": "Not Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "42"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "47"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "41"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "130"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "230"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "227"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "230"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "687"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Race (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "American Indian or Alaska Native",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "NA",
                                            "comment": "Information has not been collected"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "NA",
                                            "comment": "Information has not been collected"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "NA",
                                            "comment": "Information has not been collected"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "NA",
                                            "comment": "Total not calculated because data are not available (NA) in one or more arms."
                                        }
                                    ]
                                },
                                {
                                    "title": "Asian",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "20"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "24"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "24"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "68"
                                        }
                                    ]
                                },
                                {
                                    "title": "Native Hawaiian or Other Pacific Islander",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "NA",
                                            "comment": "Information has not been collected"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "NA",
                                            "comment": "Information has not been collected"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "NA",
                                            "comment": "Information has not been collected"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "NA",
                                            "comment": "Total not calculated because data are not available (NA) in one or more arms."
                                        }
                                    ]
                                },
                                {
                                    "title": "Black or African American",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "16"
                                        }
                                    ]
                                },
                                {
                                    "title": "White",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "250"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "249"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "244"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "743"
                                        }
                                    ]
                                },
                                {
                                    "title": "More than one race",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "NA",
                                            "comment": "Information has not been collected"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "NA",
                                            "comment": "Information has not been collected"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "NA",
                                            "comment": "Information has not been collected"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "NA",
                                            "comment": "Total not calculated because data are not available (NA) in one or more arms."
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "9"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "21"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Region of Enrollment",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "title": "Argentina",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "23"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "26"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "24"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "73"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Hungary",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "7"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "15"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Czechia",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "16"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "15"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "17"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "48"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "United States",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "54"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "58"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "52"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "164"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "United Kingdom",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "29"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "28"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "25"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "82"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Portugal",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "15"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Canada",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "11"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "9"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "10"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "30"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "South Korea",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "14"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "16"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "16"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "46"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Finland",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "13"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Taiwan",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "17"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Brazil",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "13"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "13"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "11"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "37"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Poland",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "31"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "26"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "30"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "87"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Italy",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "21"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "22"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "22"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "65"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Israel",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "9"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "France",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "12"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "12"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "12"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "36"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Lithuania",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "13"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "16"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "16"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "45"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Estonia",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "15"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "17"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "18"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "50"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Croatia",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "16"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "MMSE total score at screening",
                    "description": "The Mini Mental State Examination (MMSE) is an 11-item test to assess the cognitive aspects of mental function. The subtests assess orientation, memory, attention, language, and visual construction. The scores for each item is dichotomous (1 = response is correct, 0 = response is incorrect). Total score of the 11 items ranges from 0 to 30 (higher score indicates lower deficit).",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "units on a scale",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "17.6",
                                            "spread": "2.9"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "17.4",
                                            "spread": "3.0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "17.5",
                                            "spread": "3.0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "17.5",
                                            "spread": "3.0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Change in Cognition",
                    "description": "Change from baseline to Week 24 in Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog) total score.\n\nThe Alzheimer's Disease Assessment Scale - Cognitive subscale (ADAS-cog) is a 11-item neuropsychological test that assess the severity of cognitive impairment. The items determine the patient's orientation, memory, language, and praxis. Total score of the 11 items range from 0 to 70 (lower score indicates lower cognitive impairment).",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine, and who had a valid baseline assessment and at least one valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline and Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 10 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        },
                        {
                            "id": "OG002",
                            "title": "Idalopirdine 30 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "278"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "282"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "275"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.64",
                                            "spread": "0.39"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.55",
                                            "spread": "0.39"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "1.27",
                                            "spread": "0.39"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "groupDescription": "For demonstrating efficacy of a dose, change in cognition (ADAS-cog) and either change in daily functioning (ADCS-ADL23) or change in global clinical impression (ADCS-CGIC) at Week 24 had to show statistically significant favourable differences compared to placebo at Week 24. Overall, type 1 error was controlled at 5% by multiplicity adjustment. Testing of the doses was done in a gated manner, first testing 30 mg at a 5% significance level, and only if found efficacious, then moving on to 10 mg.",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "1.000",
                            "pValueComment": "Corrected for multiplicity",
                            "statisticalMethod": "Mixed Models Analysis",
                            "statisticalComment": "Treatment, country, MMSE stratum, week as fixed effects, baseline score, treatment-by-week, MMSE stratum-by-week, and baseline-by-week interactions",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "-0.09",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-1.10",
                            "ciUpperLimit": "0.92",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.51",
                            "estimateComment": "A negative mean difference indicates a treatment effect in favour of idalopirdine"
                        },
                        {
                            "groupIds": [
                                "OG000",
                                "OG002"
                            ],
                            "groupDescription": "For demonstrating efficacy of a dose, change in cognition (ADAS-cog) and either change in daily functioning (ADCS-ADL23) or change in global clinical impression (ADCS-CGIC) at Week 24 had to show statistically significant favourable differences compared to placebo at Week 24. Overall, type 1 error was controlled at 5% by multiplicity adjustment. Testing of the doses was done in a gated manner, first testing 30 mg at a 5% significance level, and only if found efficacious, then moving on to 10 mg.",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.2223",
                            "pValueComment": "Corrected for multiplicity according to the multiple testing procedure",
                            "statisticalMethod": "Mixed Models Analysis",
                            "statisticalComment": "Treatment, country, MMSE stratum, week as fixed effects, baseline score, treatment-by-week, MMSE stratum-by-week, and baseline-by-week interactions",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "0.63",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.38",
                            "ciUpperLimit": "1.65",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.52",
                            "estimateComment": "A negative mean difference indicates a treatment effect in favour of idalopirdine."
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Daily Functioning",
                    "description": "Change from baseline to Week 24 in Alzheimer's Disease Cooperative Study - Activities of Daily Living Inventory (ADCS-ADL23) total score.\n\nThe Alzheimer's Disease Cooperative Study - Activities of Daily Living (ADCS-ADL23) is a 23-item clinician-rated inventory to assess activities of daily living (conducted with a caregiver or informant). Each item comprises a series of hierarchical sub-questions, ranging from the highest level of independent performance to a complete loss for each activity. Total score of the 23 items ranges from 0 to 78 (higher score indicates lower disability).",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine, and who had a valid baseline assessment and at least one valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline and Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 10 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        },
                        {
                            "id": "OG002",
                            "title": "Idalopirdine 30 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "278"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "282"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "275"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-1.39",
                                            "spread": "0.49"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-1.22",
                                            "spread": "0.49"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-1.36",
                                            "spread": "0.49"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "groupDescription": "For demonstrating efficacy of a dose, change in cognition (ADAS-cog) and either change in daily functioning (ADCS-ADL23) or change in global clinical impression (ADCS-CGIC) at Week 24 had to show statistically significant favourable differences compared to placebo at Week 24. Overall, type 1 error was controlled at 5% by multiplicity adjustment. Testing of the doses was done in a gated manner, first testing 30 mg at a 5% significance level, and only if found efficacious, then moving on to 10 mg.",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "1.000",
                            "pValueComment": "Corrected for multiplicity according to the multiple testing procedure",
                            "statisticalMethod": "Mixed Models Analysis",
                            "statisticalComment": "Treatment, country, MMSE stratum, week as fixed effects, baseline score, treatment-by-week, MMSE stratum-by-week, and baseline-by-week interactions",
                            "paramType": "Mean Difference (Net)",
                            "paramValue": "0.17",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-1.11",
                            "ciUpperLimit": "1.46",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.65",
                            "estimateComment": "A positive mean difference indicates a treatment effect in favour of idalopirdine."
                        },
                        {
                            "groupIds": [
                                "OG000",
                                "OG002"
                            ],
                            "groupDescription": "For demonstrating efficacy of a dose, change in cognition (ADAS-cog) and either change in daily functioning (ADCS-ADL23) or change in global clinical impression (ADCS-CGIC) at Week 24 had to show statistically significant favourable differences compared to placebo at Week 24. Overall, type 1 error was controlled at 5% by multiplicity adjustment. Testing of the doses was done in a gated manner, first testing 30 mg at a 5% significance level, and only if found efficacious, then moving on to 10 mg.",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "1.000",
                            "pValueComment": "Corrected for multiplicity according to the multiple testing procedure",
                            "statisticalMethod": "Mixed Models Analysis",
                            "statisticalComment": "Treatment, country, MMSE stratum, week as fixed effects, baseline score, treatment-by-week, MMSE stratum-by-week, and baseline-by-week interactions",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "0.03",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-1.27",
                            "ciUpperLimit": "1.33",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.66",
                            "estimateComment": "A positive mean difference indicates a treatment effect in favour of idalopirdine."
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Global Impression",
                    "description": "Alzheimer's Disease Cooperative Study - Clinical Global Impression of Change (ADCS-CGIC) score at Week 24.\n\nThe Alzheimer's Disease Cooperative Study - Clinical Global Impression of Change is a semi-structured interview to assess clinically relevant changes in patients with AD. The items determine cognition, behavior, social and daily functioning. Severity at baseline is rated on a 7-point scale from 1 (normal, not ill at all) to 7 (among the most extremely ill patients). The clinically relevant change from baseline is rated on a 7-point scale from 1 (marked improvement) to 7 (marked worsening).",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine, and who had a valid baseline assessment and at least one valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline and Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 10 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        },
                        {
                            "id": "OG002",
                            "title": "Idalopirdine 30 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "277"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "282"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "275"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "4.30",
                                            "spread": "0.06"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "4.24",
                                            "spread": "0.06"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "4.35",
                                            "spread": "0.06"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "groupDescription": "For demonstrating efficacy of a dose, change in cognition (ADAS-cog) and either change in daily functioning (ADCS-ADL23) or change in global clinical impression (ADCS-CGIC) at Week 24 had to show statistically significant favourable differences compared to placebo at Week 24. Overall, type 1 error was controlled at 5% by multiplicity adjustment. Testing of the doses was done in a gated manner, first testing 30 mg at a 5% significance level, and only if found efficacious, then moving on to 10 mg.",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "1.000",
                            "pValueComment": "Corrected for multiplicity according to the multiple testing procedure",
                            "statisticalMethod": "Mixed Models Analysis",
                            "statisticalComment": "Treatment, country, MMSE stratum, week as fixed effects, baseline score, treatment-by-week, MMSE stratum-by-week, and baseline-by-week interactions",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "-0.07",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.23",
                            "ciUpperLimit": "0.10",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.08",
                            "estimateComment": "A negative mean difference indicates a treatment effect in favour of idalopirdine."
                        },
                        {
                            "groupIds": [
                                "OG000",
                                "OG002"
                            ],
                            "groupDescription": "For demonstrating efficacy of a dose, change in cognition (ADAS-cog) and either change in daily functioning (ADCS-ADL23) or change in global clinical impression (ADCS-CGIC) at Week 24 had to show statistically significant favourable differences compared to placebo at Week 24. Overall, type 1 error was controlled at 5% by multiplicity adjustment. Testing of the doses was done in a gated manner, first testing 30 mg at a 5% significance level, and only if found efficacious, then moving on to 10 mg.",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "1.000",
                            "pValueComment": "Corrected for multiplicity according to the multiple testing procedure",
                            "statisticalMethod": "Mixed Models Analysis",
                            "statisticalComment": "Treatment, country, MMSE stratum, week as fixed effects, baseline score, treatment-by-week, MMSE stratum-by-week, and baseline-by-week interactions",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "0.05",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.12",
                            "ciUpperLimit": "0.21",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.09",
                            "estimateComment": "A negative mean difference indicates a treatment effect in favour of idalopirdine."
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Behavioural Disturbance",
                    "description": "Change from baseline to Week 24 in Neuropsychiatric Inventory (NPI) total score.\n\nThe Neuropsychiatric Inventory is a 12-item structured interview with a caregiver to assess behavioural disturbances. The NPI comprises 10 behavioural and 2 neurovegetative items. Each item consists of a screening question and several sub-questions that are rated no (not present) or yes (present). Each item is rated for frequency (a 4-point scale from 1 \\[occasionally\\] to 4 \\[very frequent\\]) and severity (a 3-point scale from 1 \\[mild\\] to 3 \\[marked\\]). The total NPI score is the frequency ratings multiplied by the severity ratings and ranges from 0 to 144 (higher score indicates worse outcome).",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine, and who had a valid baseline assessment and at least one valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline and Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 10 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        },
                        {
                            "id": "OG002",
                            "title": "Idalopirdine 30 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "278"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "282"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "275"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.31",
                                            "spread": "0.59"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.94",
                                            "spread": "0.59"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-0.54",
                                            "spread": "0.60"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Individual Behavioural Disturbance Items",
                    "description": "Change in single NPI item scores at Week 24.\n\nThe Neuropsychiatric Inventory is a 12-item structured interview with a caregiver to assess behavioural disturbances. The NPI comprises 10 behavioural and 2 neurovegetative items. Each item consists of a screening question and several sub-questions that are rated no (not present) or yes (present). Each item is then rated for frequency (a 4-point scale from 1 \\[occasionally\\] to 4 \\[very frequent\\]) and severity (a 3-point scale from 1 \\[mild\\] to 3 \\[marked\\]). Total score for each single NPI item ranges from 0-12 (frequency multiplied by severity), where higher scores represent worse outcome.",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine and who had a valid baseline assessment and at least one valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure/item assessed",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline and Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 10 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        },
                        {
                            "id": "OG002",
                            "title": "Idalopirdine 30 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "278"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "282"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "275"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Delusions",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.01",
                                            "spread": "0.08"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.18",
                                            "spread": "0.08"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0.00",
                                            "spread": "0.08"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Hallucinations",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.00",
                                            "spread": "0.04"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.06",
                                            "spread": "0.04"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-0.03",
                                            "spread": "0.04"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Agitation/aggression",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.02",
                                            "spread": "0.11"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.06",
                                            "spread": "0.11"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-0.06",
                                            "spread": "0.11"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Depression/dysphoria",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.20",
                                            "spread": "0.10"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.08",
                                            "spread": "0.10"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-0.14",
                                            "spread": "0.10"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Anxiety",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.05",
                                            "spread": "0.11"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.06",
                                            "spread": "0.11"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-0.02",
                                            "spread": "0.11"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Elation/euphoria",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.01",
                                            "spread": "0.04"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.05",
                                            "spread": "0.04"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-0.02",
                                            "spread": "0.04"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Apathy/indifference",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.00",
                                            "spread": "0.17"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.19",
                                            "spread": "0.17"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-0.24",
                                            "spread": "0.17"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Disinhibition",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.08",
                                            "spread": "0.09"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.04",
                                            "spread": "0.09"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0.02",
                                            "spread": "0.09"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Irritability/lability",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.03",
                                            "spread": "0.12"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.05",
                                            "spread": "0.12"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-0.17",
                                            "spread": "0.12"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Aberrant motor behaviour",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.03",
                                            "spread": "0.14"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.06",
                                            "spread": "0.14"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0.12",
                                            "spread": "0.14"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Sleep",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.04",
                                            "spread": "0.12"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.07",
                                            "spread": "0.12"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0.12",
                                            "spread": "0.12"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Appetite/eating disorder",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.14",
                                            "spread": "0.14"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.30",
                                            "spread": "0.14"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-0.07",
                                            "spread": "0.14"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in NPI Anxiety Item Score in Patients With an NPI Anxiety Item Score of at Least 2 at Baseline",
                    "description": "Change from baseline to Week 24 in NPI anxiety item score in patients with an NPI anxiety item score of at least 2 at baseline\n\nThe Neuropsychiatric Inventory is a 12-item structured interview with a caregiver to assess behavioural disturbances. The NPI comprises 10 behavioural and 2 neurovegetative items. Each item consists of a screening question and several sub-questions that are rated no (not present) or yes (present). Each item is then rated for frequency (a 4-point scale from 1 \\[occasionally\\] to 4 \\[very frequent\\]) and severity (a 3-point scale from 1 \\[mild\\] to 3 \\[marked\\]). The total score for the NPI anxiety item ranges from 0-12 (frequency multiplied by severity), where a higher score represents a worse outcome.",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine and who had a valid baseline assessment and at least one valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome/item measure assessed",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline and Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 10 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        },
                        {
                            "id": "OG002",
                            "title": "Idalopirdine 30 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "71"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "56"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "61"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-1.48",
                                            "spread": "0.38"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-1.82",
                                            "spread": "0.40"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-1.69",
                                            "spread": "0.40"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Number of Participants With Clinical Improvement",
                    "description": "Clinical response at Week 24 (based on pre-specified ADAS-cog, ADCS-ADL23, and ADCS-CGIC changes \\[change in ADAS-cog below or equal to -4, change in ADCS-ADL23 at least 0, and ADCS-CGIC below or equal to 4\\])",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine and who had a valid baseline assessment and at least one valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 10 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        },
                        {
                            "id": "OG002",
                            "title": "Idalopirdine 30 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "255"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "257"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "249"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "20"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "33"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "22"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Number of Participants With Clinical Worsening",
                    "description": "Clinical worsening at Week 24 (Based on pre-specified ADAS-cog, ADCS-ADL23, and ADCS-CGIC changes \\[change in ADAS-cog above or equal to 4, change in ADCS-ADL23 below 0, and ADCS-CGIC above 4\\])",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine and who had a valid baseline assessment and at least one valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 10 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        },
                        {
                            "id": "OG002",
                            "title": "Idalopirdine 30 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "255"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "257"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "249"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "27"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "28"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "27"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Cognitive Aspects of Mental Function",
                    "description": "Change from baseline to Week 24 in Mini Mental State Examination (MMSE). The Mini Mental State Examination (MMSE) is an 11-item test to assess the cognitive aspects of mental function. The subtests assess orientation, memory, attention, language, and visual construction. The scores for each item is dichotomous (1 = response is correct, 0 = response is incorrect). Total score of the 11 items ranges from 0 to 30 (higher score indicates lower deficit).",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine and who had a valid baseline assessment and at least one valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline and Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 10 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        },
                        {
                            "id": "OG002",
                            "title": "Idalopirdine 30 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "258"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "257"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "248"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.24",
                                            "spread": "0.21"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.45",
                                            "spread": "0.21"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-0.34",
                                            "spread": "0.21"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Health-related Quality of Life (EQ-5D) Utility Score",
                    "description": "Change from baseline to Week 24 in EuroQol 5-dimensional (EQ-5D) utility score\n\nThe EQ-5D is a patient-reported assessment that measures the patient's well-being. It consists of an utility score based on 5 descriptive items (mobility, self-care, usual activities, pain/discomfort, and depression/anxiety) and a Visual Analogue Scale (VAS). Each descriptive item is rated on a 3-point index ranging from 1 (no problems) to 3 (extreme problems) that is used for calculating a single summary index (from 0 to 1). A higher EQ-5D score indicates a worse outcome.",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine and who had a valid baseline assessment and at least one valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline and Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 10 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        },
                        {
                            "id": "OG002",
                            "title": "Idalopirdine 30 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "274"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "275"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "266"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.03",
                                            "spread": "0.01"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.02",
                                            "spread": "0.01"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0.01",
                                            "spread": "0.01"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Health-related Quality of Life (EQ-5D VAS)",
                    "description": "Change from baseline to Week 24 in EQ-5D Visual Analogue Scale (EQ-5D VAS).\n\nThe EQ-5D is a patient-reported assessment that measures the patient's well-being. It consists of an utility score based on 5 descriptive items (mobility, self-care, usual activities, pain/discomfort, and depression/anxiety) and a Visual Analogue Scale (VAS). The VAS ranges from 0 (worst imaginable health state) to 100 (best imaginable health state).",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine and who had a valid baseline assessment and at least one valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline and Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 10 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        },
                        {
                            "id": "OG002",
                            "title": "Idalopirdine 30 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "274"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "274"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "266"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.35",
                                            "spread": "0.99"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.87",
                                            "spread": "0.99"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "1.00",
                                            "spread": "1.01"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "5",
            "timeFrame": "Baseline to end of study at Week 24",
            "description": "Treatment-Emergent Adverse Events are reported in this section",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "Placebo",
                    "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally",
                    "deathsNumAffected": 1,
                    "deathsNumAtRisk": 282,
                    "seriousNumAffected": 12,
                    "seriousNumAtRisk": 282,
                    "otherNumAffected": 33,
                    "otherNumAtRisk": 282
                },
                {
                    "id": "EG001",
                    "title": "Idalopirdine 10 mg",
                    "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 285,
                    "seriousNumAffected": 13,
                    "seriousNumAtRisk": 285,
                    "otherNumAffected": 26,
                    "otherNumAtRisk": 285
                },
                {
                    "id": "EG002",
                    "title": "Idalopirdine 30 mg",
                    "description": "Idalopirdine adjunct to 20 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally",
                    "deathsNumAffected": 1,
                    "deathsNumAtRisk": 281,
                    "seriousNumAffected": 15,
                    "seriousNumAtRisk": 281,
                    "otherNumAffected": 31,
                    "otherNumAtRisk": 281
                }
            ],
            "seriousEvents": [
                {
                    "term": "Lymphadenitis",
                    "organSystem": "Blood and lymphatic system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Acute myocardial infarction",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Angina pectoris",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Atrioventricular block complete",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Bradycardia",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Cardiac arrest",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Cardiac failure",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Myocardial infarction",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 2,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Dysphagia",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Gastrooesophageal reflux disease",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Inguinal hernia",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Pancreatitis",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Upper gastrointestinal haemorrhage",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Gait disturbance",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Bile duct obstruction",
                    "organSystem": "Hepatobiliary disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Cholelithiasis",
                    "organSystem": "Hepatobiliary disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Pneumonia bacterial",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 2,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Urinary tract infection bacterial",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Cervical vertebral fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Rib fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Anal cancer",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Bladder transitional cell carcinoma",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Carotid sinus syndrome",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Cerebrovascular accident",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Dementia",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Embolic stroke",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Encephalopathy",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Epilepsy",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Ischaemic stroke",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Syncope",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Transient ischaemic attack",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Aggression",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Delirium",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 2,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Depressive symptom",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Hallucination",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Hallucinations, mixed",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Suicidal ideation",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Acute kidney injury",
                    "organSystem": "Renal and urinary disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Urinary retention",
                    "organSystem": "Renal and urinary disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Benign prostatic hyperplasia",
                    "organSystem": "Reproductive system and breast disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 101
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 113
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 112
                        }
                    ]
                },
                {
                    "term": "Laryngeal haemorrhage",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 281
                        }
                    ]
                },
                {
                    "term": "Circulatory collapse",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 281
                        }
                    ]
                }
            ],
            "otherEvents": [
                {
                    "term": "Accidental overdose",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 33,
                            "numAtRisk": 282
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 26,
                            "numAtRisk": 285
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 31,
                            "numAtRisk": 281
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": false,
                "restrictiveAgreement": false
            },
            "pointOfContact": {
                "title": "Email contact via",
                "organization": "H. Lundbeck A/S",
                "email": "LundbeckClinicalTrials@lundbeck.com",
                "phone": "+4536301311"
            }
        }
    },
    "target_category": "cognitive enhancer",
    "drug": [
        "Idalopirdine (Lu AE58054) \u2014 selective 5-HT6 receptor antagonist (small molecule)",
        "Donepezil \u2014 acetylcholinesterase inhibitor (background therapy in the trial)"
    ],
    "placebo": [
        "Placebo"
    ],
    "explanation_target": [
        "Reason: The trial tests idalopirdine added to donepezil to produce symptomatic benefit (improve cognition) in mild-to-moderate AD. Idalopirdine is a small-molecule, selective 5-HT6 receptor antagonist developed to enhance cognition rather than to modify core AD pathology (amyloid/tau). \ue200cite\ue202turn1search3\ue202turn0search3\ue201",
        "Act (key extracted details + supporting searches): The study title and description state the objective is to establish efficacy of idalopirdine as adjunctive (to donepezil) symptomatic treatment in mild\u2013moderate AD (24-week, double-blind, placebo-controlled fixed-dose trials). This is consistent with symptomatic cognitive enhancement rather than a disease-modifying approach. \ue200cite\ue202turn1search6\ue202turn0search4\ue201",
        "Act (mechanism / preclinical): Idalopirdine (Lu AE58054) acts as a selective 5-HT6 receptor antagonist and in preclinical work potentiated effects of donepezil on neurotransmitters and network activity thought to support cognition. This pharmacology supports classification as a cognitive enhancer. \ue200cite\ue202turn0search3\ue202turn0search6\ue201",
        "Act (clinical outcome context): Large Phase III programs (three 24-week randomized trials) evaluated idalopirdine adjunctive to cholinesterase inhibitors; these trials were designed as symptomatic cognition studies (ADAS-Cog primary endpoint). The Phase III program ultimately did not demonstrate efficacy across the prespecified endpoints. These trial descriptions and results confirm the intention of symptomatic cognitive enhancement (and that the drug is a small-molecule cognitive enhancer). \ue200cite\ue202turn1search2\ue202turn1search0\ue201",
        "Reflect: Given the intervention (small-molecule 5-HT6 antagonist), its intended symptomatic cognitive effect when added to an AChEI, and absence of any amyloid/tau-targeting biologic mechanism, the correct category is 'cognitive enhancer'. No credible evidence in the provided description indicates a disease-modifying biologic or small-molecule targeting AD pathology, nor a trial focused on neuropsychiatric symptoms or diagnostics\u2014therefore 'cognitive enhancer' is the appropriate classification. \ue200cite\ue202turn1search3\ue202turn1search2\ue201"
    ],
    "agent_type": "D) Neurotransmitter Receptors",
    "explanation_agent": [
        "Reason: The investigational drug idalopirdine (Lu AE58054) is a selective antagonist of the serotonin 5-HT6 receptor and was studied as an add-on symptomatic cognitive enhancer to donepezil in mild\u2013moderate AD. A 5-HT6 receptor is a neurotransmitter receptor, so the trial\u2019s biological focus is on modulating neurotransmitter systems to improve cognition. \ue200cite\ue202turn0search0\ue202turn0search4\ue201",
        "Act: Key extracted details \u2014 idalopirdine (Lu AE58054) = selective 5-HT6 receptor antagonist (small molecule); studied adjunctive to donepezil (an acetylcholinesterase inhibitor) in symptomatic cognition trials (Phase II and Phase III programs). Phase III headline results reported failure to meet the primary cognitive endpoint, confirming these were symptomatic cognitive-enhancement studies rather than amyloid- or tau-directed disease-modifying programs. \ue200cite\ue202turn0search0\ue202turn0search4\ue202turn0search9\ue201",
        "Reflect: Classification check \u2014 5-HT6 is unequivocally a neurotransmitter receptor (serotonin receptor) and the intervention aims to enhance neurotransmission/cognition rather than target core AD pathologies (amyloid/tau). Therefore CADRO category D) Neurotransmitter Receptors is the correct and most specific assignment. Donepezil (background therapy) is an acetylcholinesterase inhibitor (also acting on neurotransmission), which further supports a neurotransmitter-receptor / neurotransmission-focused symptomatic strategy. \ue200cite\ue202turn0search1\ue202turn0search0\ue201",
        "Web-search sources used (top results):",
        "- Idalopirdine effects on monoamines/glutamate and 5-HT6 pharmacology (PubMed article describing Lu AE58054 as a high-affinity selective 5-HT6 antagonist and its neurotransmitter effects). \ue200cite\ue202turn0search0\ue201",
        "- LADDER Phase 2 randomized trial of idalopirdine as adjunct to donepezil (trial description showing symptomatic cognition endpoint). \ue200cite\ue202turn0search4\ue201",
        "- Otsuka / Lundbeck headline on Phase III idalopirdine not meeting primary endpoint (STARSHINE/Phase III program outcome). \ue200cite\ue202turn0search9\ue201",
        "- Donepezil mechanism review (acetylcholinesterase inhibitor; background symptomatic therapy in the trial). \ue200cite\ue202turn0search1\ue201",
        "- Pharmacology / compound summaries for Lu AE58054 (preclinical / vendor summary of idalopirdine pharmacology). \ue200cite\ue202turn0search2\ue201"
    ]
}